DAWN - Day One Biopharmaceuticals, Inc. Stock Price, Fair Value and News

DAWN is the stock ticker symbol of Day One Biopharmaceuticals, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Mar 12 2025, market cap of Day One Biopharmaceuticals, Inc. is 890.91 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check DAWN's fair value in chart for subscribers.

The fair value guage provides a quick view whether DAWN is over valued or under valued. Whether Day One Biopharmaceuticals, Inc. is cheap or expensive depends on the assumptions which impact Day One Biopharmaceuticals, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DAWN.

As of Wed Mar 12 2025, DAWN's PE ratio (Price to Earnings) is -9.33 and Price to Sales (PS) ratio is 4.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DAWN PE ratio will change depending on the future growth rate expectations of investors.